Job Posts View All

Skyward Specialty Insurance - AI Stock Analysis

Analysis generated March 5, 2025

Skyward Specialty Insurance is a leading provider of specialized property and casualty insurance. The company focuses on innovative and bespoke solutions across various industry sectors. Known for its underwriting proficiency and risk assessment capabilities, Skyward Specialty Insurance has built a robust portfolio that positions it well within the insurance market. With a skilled workforce and a commitment to customer-centric strategies, the company continues to expand its footprint.

Fundamental Analysis

In the last quarter, Skyward Specialty Insurance reported revenue of $301M, marking a 7.48% increase from the previous quarter. Year-over-year, this represents a 25.78% growth, indicating a consistent and positive upward trajectory in revenue generation.

The company's net income stood at $37M for the last quarter, reflecting an 18.40% increase from the preceding quarter and an impressive 68.89% rise year-over-year. This suggests strong profitability and efficient cost management.

EBITDA was reported at $49M, a 14.52% increase from the prior quarter and a 60.03% growth year-over-year. This growth in EBITDA underscores the company's solid operational performance and ability to generate earnings.

The current price-to-earnings (P/E) ratio is 18.86, suggesting that the stock is neither overvalued nor undervalued. It appears to be trading within a normal range relative to its earnings.

However, it is worth noting that there have been insider stock sales recently. Such activities by insiders can be a bearish signal, as these individuals have an in-depth understanding of the company's future prospects.

Technical Analysis

Today's stock price for Skyward Specialty Insurance is $52.15, showing an 8.85% increase compared to a month ago and a 46.24% rise year-over-year. This points towards a positive trend in the stock's performance.

The current simple moving average (SMA10) is $52.04, slightly up from the previous SMA10 of $51.69, indicating a potential upward momentum in the stock price. The relative strength index (RSI) is 66.2, which is neutral. Generally, an RSI between 30 and 70 is considered neutral, suggesting that the stock is neither overbought nor oversold.

Thus, the overall technical indicators depict a bullish trend for Skyward Specialty Insurance.

Alternative Data Analysis

Regarding job postings, Skyward Specialty Insurance has 5 open positions, a decrease of 67% over the last few months. This trend might indicate efforts to improve margins or cut costs, which is not ideal for a growing company.

Employee sentiment at the company is overwhelmingly positive, with 92% of employees having a favorable outlook. This high employee morale could contribute to higher productivity and business performance.

Skyward Specialty Insurance's website had an estimated 11,000 visitors recently, a 57% increase in the past couple of months. This uptrend suggests potential growth in customer acquisition.

On social media, the company has 100 followers on Twitter, with a 3% increase in followers recently. While modest, it indicates a rising interest in the company's activities and offerings.

Additionally, AltIndex's AI score for Skyward Specialty Insurance is 70, which signals a "buy" recommendation based on a thorough analysis incorporating fundamental, technical, and alternative data.

Conclusion

Based on our extensive analysis of Skyward Specialty Insurance, the stock presents a compelling case. The fundamental metrics exhibit robust growth across revenue, net income, and EBITDA, reflecting strong operational performance. The technical indicators support a bullish trend, while alternative data suggests positive employee sentiment and increased customer interest. Although the reduction in job postings and insider stock sales are points of cautious observation, the overall outlook remains positive. Consequently, Skyward Specialty Insurance appears to be a promising investment opportunity, with current indicators suggesting a "buy" recommendation.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.